COMMUNIQUÉS West-GlobeNewswire

Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2018

26/04/2018 - 15:00

SALT LAKE CITY, April 26, 2018 (GLOBE NEWSWIRE) -- In the first calendar quarter (1Q) of 2018, Utah Medical Products, Inc. (Nasdaq: UTMD ) attained results consistent with achieving its financial goals for year 2018. [...]

Alphatec to Report First Quarter 2018 Financial Results on May 10, 2018

26/04/2018 - 15:00

CARLSBAD, Calif., April 26, 2018 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“Alphatec” or the “Company”) (Nasdaq: ATEC ), a provider of innovative spine surgery solutions with a mission to improve patient lives [...]

Knalysis Technologies is a KIRA Award Finalist!

26/04/2018 - 14:48

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, April 26, 2018 (GLOBE NEWSWIRE) -- Knalysis Technologies (“Knalysis”), a subsidiary of Canada House Wellness Group Inc. (CSE: [...]

BioCorRx CEO Brady Granier and Actor Jeremy Miller Appear on Varney & Co. on Fox Business to Discuss the Company's Sustained Release Naltrexone Implant for Alcohol Use Disorder

26/04/2018 - 14:47

ANAHEIM, CA, April 26, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the "Company") , a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced that Brady [...]

Minerva Neurosciences to Report First Quarter 2018 Financial Results and Business Updates on May 3, 2018

26/04/2018 - 14:30

Management to host conference call WALTHAM, Mass., April 26, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV ), a clinical-stage biopharmaceutical company focused on the development of therapies to [...]

Yield10 Addresses Application of Metabolic Engineering to Increase Crop Yield in Paper Published in Plant Science

26/04/2018 - 14:30

Chief Science Officer Kristi Snell also confirmed as a keynote speaker at upcoming plant meeting WOBURN, Mass., April 26, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ), a Company developing new [...]

Emisphere Amends License Agreement with Novo Nordisk

26/04/2018 - 14:30

Emisphere to Receive $7 Million Payment ROSELAND, N.J., April 26, 2018 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCBB: EMIS ) today announced that it has amended its existing 2015 Development and License [...]

Progenics Pharmaceuticals Sets First Quarter 2018 Financial Results Call for May 9

26/04/2018 - 14:30

NEW YORK, April 26, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX ), an oncology company developing innovative medicines and imaging analytical tools for targeting and treating cancer, announced [...]

Corvus Pharmaceuticals Announces Initiation of Phase 1/1b Clinical Trial of Investigational Anti-CD73 Antibody, CPI-006, in Patients with Advanced Cancer

26/04/2018 - 14:30

Three-arm Trial Will Evaluate CPI-006 as Monotherapy, in Combination with CPI-444 Adenosine Antagonist and in Combination with Pembrolizumab BURLINGAME, Calif., April 26, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals [...]

Agritek Holdings, Inc. Announces Purchase And Transfer Of Tier One Recreational License For Colorado On Behalf Of Approved Partner Licensee With Existing Cannabis Operations

26/04/2018 - 14:30

Company Expands Operations In Colorado On Heel Of New Deal With President Trump And Senator Cory Gardner Clearing Way For Colorado Medical And Recreational Cannabis LOS ANGELES, CA, April 26, 2018 (GLOBE NEWSWIRE) -- [...]

William Hartman, CEO of Premier Biomedical, Returns to Uptick Newswire’s “Stock Day” Podcast

26/04/2018 - 14:30

PHOENIX, April 26, 2018 (GLOBE NEWSWIRE) -- William Hartman, CEO of Premier Biomedical Inc. (OTCBB: BIEI ) ("the Company") joined Everett Jolly on Uptick Newswire’s “Stock Day” podcast to discuss recent company [...]

Alder BioPharmaceuticals® Appoints Jeremy Green to its Board of Directors

26/04/2018 - 14:30

BOTHELL, Wash., April 26, 2018 (GLOBE NEWSWIRE) -- Alder Biopharmaceuticals, Inc. (NASDAQ: ALDR ) (“Alder” or the “Company”), a biopharmaceutical company focused on developing novel therapeutic antibodies for the [...]

Imagin Gains Momentum; Positive Progress in Research Study

26/04/2018 - 14:30

VANCOUVER, British Columbia and BOSTON, April 26, 2018 (GLOBE NEWSWIRE) -- Imagin Medical (CSE:IME) (OTC PINK:IMEXF) (Frankfurt & Stuttgart Symbol:DPD2) (the “Company”) is providing the following update on the [...]

Histogenics Corporation to Report First Quarter 2018 Financial Results on May 10, 2018

26/04/2018 - 14:30

WALTHAM, Mass., April 26, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Nasdaq: HSGX ), a leader in the development of restorative cell therapies that may offer rapid-onset pain relief and restored function, [...]

Navamedic ASA: Strengthens international IP position with two new patents in the U.S.

26/04/2018 - 14:22

Oslo, 26 April 2018 - Navamedic ASA announced today that the United States Patent and Trademark Office has granted patents for the Sippi® base technology for using capacitance as a volume measurement and silicone oil as [...]

PolarityTE Leadership to Participate in the Symposium on Advanced Wound Care

26/04/2018 - 14:15

SALT LAKE CITY, April 26, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq: COOL ) today announced attendance and participation in the Symposium on Advanced Wound Care Spring (SAWC Spring) Wound Healing Society (WHS) [...]

Aino Health AB (publ): Aino Health gains representation in the United Arab Emirates

26/04/2018 - 14:01

April 26, 2018 Aino Health gains representation in the United Arab Emirates Aino Health has entered into an exclusive partnership agreement with Emirates Artificial Intelligence Technologies LLC. Emirates A.I. as the [...]

Achaogen Wins CARB-X Funding Award to Advance Development of Novel Aminoglycoside to Fight Highly-Resistant Infections

26/04/2018 - 14:01

-- CARB-X funding to support Achaogen’s early-stage aminoglycoside program developing antibiotics for difficult to treat infections that are associated with high mortality -- -- Awarded Up to $2.4 million over appr [...]

Rexahn to Present Clinical Data at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

26/04/2018 - 14:00

Preliminary Safety and Efficacy Data from Phase 1b/2a Trial of RX-5902 in Advanced Triple Negative Breast Cancer Updated Safety and Efficacy Data on RX-3117 in Advanced Urothelial (Bladder) Cancer ROCKVILLE, Md., April [...]